The Latest Breaking News from FDA

The pharma industry is anticipated to stay buoyed in the years to come with consistent medical breakthroughs and rising need to serve an aging population. Therefore, pharma stocks Johnson & Johnson (JNJ), Novartis AG (NVS), and Dr. Reddy's Laboratories (RDY), which possess promising pipelines, could be wise portfolio additions now.…

A federal judge has ruled that West Virginia can restrict the sale of the abortion pill

James “Jim" Jones will start at the new Human Foods Program Sept. 24. The program will oversee food safety, chemical safety and nutrition.

Reason's Nick Gillespie talked with MAPS founder Rick Doblin about the imminent FDA approval of MDMA- and psilocybin-assisted therapy at the Psychedelic Science conference in Denver.

The FDA just approved an RSV vaccine that can be given in the third trimester of pregnancy.

Six people were hospitalized earlier this year for listeriosis, three of whom died. Two of those who survived the infection said they had milkshakes from Frugals in Tacoma, Wash., before getting sick.

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

Shares of REGN stock jumped Monday after the FDA approved Regeneron Pharmaceuticals' high-dose Eylea following a delay this summer.